Engage MSI Media & expert commentary
Independent perspective on
medicines security.
MSI welcomes serious media enquiries seeking evidence-led context on the systems, risks and policy choices shaping the availability and resilience of medicines.
Commentary availability
Context for consequential public questions.
At this stage, MSI offers expert commentary and background briefings. This page does not imply previous media coverage, endorsement or a standing spokesperson relationship.
- Medicines shortages and national resilience
- Pharmaceutical supply-chain dependencies
- Secure medicines manufacturing and industrial strategy
- AI, data and early-warning intelligence
- Regulatory cooperation and geopolitical risk
- Medicines-security governance and leadership
Please state the publication or programme, intended use and deadline. Availability cannot be guaranteed.